We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
Cap. Flow
+$224M
Cap. Flow %
0.26%
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$72.5M
2
IWB icon
iShares Russell 1000 ETF
IWB
+$54.4M
3
BX icon
Blackstone
BX
+$44M
4
ABNB icon
Airbnb
ABNB
+$37.4M
5
EG icon
Everest Group
EG
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 26.73%
2 Healthcare 12.76%
3 Financials 12.67%
4 Consumer Discretionary 11.16%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATIP
3876
DELISTED
ATI Physical Therapy, Inc.
ATIP
$8 ﹤0.01%
1
-448
-100% -$3.63K
KWK
3877
DELISTED
QUICKSILVER RESOURCES INC
KWK
$6 ﹤0.01%
1,604
CYCN icon
3878
Cyclerion Therapeutics
CYCN
$16.7M
$3 ﹤0.01%
1
-21
-95% -$76
ADVNB
3879
DELISTED
Advanta Corp Class B
ADVNB
$3 ﹤0.01%
1,650
SLDB icon
3880
Solid Biosciences
SLDB
$900M
-27
Closed -$105
BBIG
3881
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$2 ﹤0.01%
31
-855
-97% -$2.26K
QTT
3882
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$2 ﹤0.01%
195
RAAS
3883
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
$1 ﹤0.01%
1,873
ABCL icon
3884
AbCellera Biologics
ABCL
$2.12B
-9,393
Closed -$60.7K
AFMD
3885
DELISTED
Affimed
AFMD
-494
Closed -$2.95K
AKA icon
3886
a.k.a. Brands
AKA
$119M
-493
Closed -$2.54K
AQB icon
3887
AquaBounty Technologies
AQB
$6.02M
-13
Closed -$92
AREN icon
3888
Arena Group
AREN
$83.8M
-393
Closed -$1.8K
BATL icon
3889
Battalion Oil
BATL
$28.8M
-80
Closed -$456
BTE icon
3890
Baytex Energy
BTE
$2.92B
-66,590
Closed -$217K
BBBY
3891
Bed Bath & Beyond
BBBY
$442M
-77,633
Closed -$2.3M
CENN icon
3892
Cenntro
CENN
$8.43M
-12
Closed -$2.14K
CISO
3893
CISO Global
CISO
$12.1M
-396
Closed -$1.06K
CLOV icon
3894
Clover Health Investments
CLOV
$2.51B
-17,242
Closed -$15.5K
CRH icon
3895
CRH
CRH
$66.8B
-30,706
Closed -$1.71M
CSTE icon
3896
Caesarstone
CSTE
$79.5M
-1,509
Closed -$7.91K
CTSO icon
3897
Cytosorbents Corp
CTSO
$22.6M
-1,897
Closed -$6.81K
CULP icon
3898
Culp Inc
CULP
$44.1M
-415
Closed -$2.06K
DLHC icon
3899
DLH Holdings
DLHC
$69.9M
-1,059
Closed -$10.9K
FCUV icon
3900
Focus Universal
FCUV
$3.65M
-7
Closed -$4.97K

Similar funds

RhumbLine Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
  • RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
  • RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
  • RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
  • RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.